21 – 30 of 138
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction : The phase 2a FLAVOUR study
- Contribution to journal › Article
-
Mark
Major adverse cardiovascular events following acute coronary syndrome in patients with bipolar disorder
- Contribution to journal › Article
-
Mark
Factors influencing kinesiophobia during the “blanking period” after radiofrequency catheter ablation in patients with atrial fibrillation by the fear-avoidance model
- Contribution to journal › Article
- 2021
-
Mark
How much is good enough? : Insights from myocardial infarction incidence during COVID-19 pandemic
- Contribution to journal › Debate/Note/Editorial
-
Mark
The impact of peripheral artery disease on major adverse cardiovascular events following myocardial infarction
- Contribution to journal › Article
-
Mark
Clopidogrel, prasugrel, and ticagrelor for all-comers with ST-segment elevation myocardial infarction
- Contribution to journal › Article
-
Mark
Plasma tumour and metabolism related biomarkers AMBP, LPL and Glyoxalase I differentiate heart failure with preserved ejection fraction with pulmonary hypertension from pulmonary arterial hypertension
- Contribution to journal › Article
-
Mark
Cardiovascular implantable electronic device therapy in patients with left ventricular assist devices : insights from TRAViATA
- Contribution to journal › Article
-
Mark
Instantaneous wave-free ratio compared with fractional flow reserve in PCI : A cost-minimization analysis
- Contribution to journal › Article
-
Mark
Long term outcome after treatment of de novo coronary artery lesions using three different drug coated balloons
- Contribution to journal › Article
